D.E. Shaw & Co
ANAC

D.E. Shaw & Co’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

D.E. Shaw & Co’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-10,000
Closed -$1.13M – 4134
2015
Q4 		$1.13M Buy
+10,000
New +$1.1M ﹤0.01% 2561

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

D.E. Shaw & Co's ANAC Position: Q2 2016 in Review

D.E. Shaw & Co sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 87,990 shares — an estimated $4.7M sold.

D.E. Shaw & Co first reported a position in ANAC in Q3 2013 and held it in 11 quarters. The position peaked at $18.4M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • D.E. Shaw & Co reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • D.E. Shaw & Co sold 87,990 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $4.7M.
  • D.E. Shaw & Co first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2013 and held it in 11 quarters.
  • D.E. Shaw & Co's ANACOR PHARMACEUTICALS INC COM position peaked at $18.4M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on D.E. Shaw & Co's 13F filing for Q2 2016, filed 15 Aug 2016.